Citra Buana Prasida (CBPE) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Citra Buana Prasida stock IDR 835, price IDR 490, upside +70.4%, quality 66 out of 100. Rating: strongly undervalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
46‑month range 113.06 IDR – 630.00 IDR · fair‑value band 542.07 IDR – 1,399 IDR · the 490.00 IDR price screens below the 835.05 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.
Follow Citra Buana Prasida in your weekly email
Every Wednesday you see whether Citra Buana Prasida is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Citra Buana Prasida Tbk operates as a property developer and manager in Indonesia. The company purchases, sells, leases, and operates apartment buildings; residential buildings; and non-residential buildings, such as storage facilities/warehouses, malls, shopping centers, and others.
Show moreShow less
It also provides houses and flats, as well as land sales activities, development of buildings, subdivision of real estate into land plots without land development, and operation of residential areas for movable homes. The company was founded in 2000 and is headquartered in Bandung, Indonesia.
PT Citra Buana Prasida Tbk is a subsidiary of PT Sandhi Parama Nusa.
Stock analysis
Citra Buana Prasida (CBPE) currently trades at 490.00 IDR, while our model-based Fair Value estimate is 835.05 IDR, implying the stock looks roughly 41% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 835.05 IDR per share, and 10 of the 16 models we run sit above the 490.00 IDR price.
Bear case: the Economic Profit group reads lowest at 258.02 IDR, and 6 of the 16 models stay below the price. Data coverage for this calculation is low.
Scenario range: 542.07 IDR (bear) to 1,399 IDR (bull), the price of 490.00 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Citra Buana Prasida reported revenue of 94.1B IDR in FY2025 versus 66.8B IDR in FY2021, a compound +8.9%/yr. Reported net income was 47.4B IDR in FY2025, compounding +12.0%/yr from FY2021.
Key figures
Market cap 665B IDR (≈ $36.9M) Micro · P/S ratio 5.89 · Net margin 59.7% · Return on equity 19.7% · Return on assets (EBIT) 15.9% (5-year average) · Operating margin 45.6% · Revenue (TTM) 112B IDR · Revenue growth (YoY) +14.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 81 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 89% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at 33% fair-value upside, at 70%, CBPE screens cheaper than that median.
Fair Value models
Bear542.07 IDRFair Value 835.05 IDRBull1,399 IDR
Price 490.00 IDR · Upside +70.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.94/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.0%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.8%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−9.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.3%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.70% → 51%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+1.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about −1.3% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate - Development · 489 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score66 · Top 25%
Fair Value upside+70.4% · Above median
Profitability
Return on equity (12 months)19.7% · Top 25%
Return on assets12.6% · Top 25%
Net margin (12 months)59.7% · Top 25%
Operating margin (12 months)45.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)14.2% · Above median
Dividend yield (12 months)0.0% · Bottom 25%
Balance sheet
Debt / equity0.02× · Lowest 25%
Valuation Multiplesvs Real Estate - Development median · lower = cheaper
P/B2.04× · Priciest 25%
P/S (12 months)5.94× · Priciest 25%
Price / free cash flow (fiscal year)12.2× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Citra Buana Prasida (CBPE) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 835.05 IDR versus a price of 490.00 IDR, about +70% upside (undervalued).
What is the fair value of CBPE?
Our model-based fair value for Citra Buana Prasida is 835.05 IDR (as of Nov 3, 2026), built from audited fundamentals. The current price: 490.00 IDR.
What is the quality score of CBPE?
Citra Buana Prasida has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Citra Buana Prasida (CBPE)?
Our model-based price target is the fair value of 835.05 IDR (as of Nov 3, 2026) from 16 valuation models. Cautious scenario 542.07 IDR, optimistic scenario 1,399 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Citra Buana Prasida stock forecast for 2026?
Our models put fair value at 835.05 IDR, about +70% upside versus a price of 490.00 IDR (undervalued). Cautious scenario 542.07 IDR, optimistic scenario 1,399 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Citra Buana Prasida (CBPE)?
Citra Buana Prasida reported trailing-twelve-month revenue of about 112B IDR (latest available figure, as of Nov 3, 2026).
What growth is priced into Citra Buana Prasida (CBPE)?
For today's price to be fair in a discounted-cash-flow model, Citra Buana Prasida would have to grow free cash flow by +1.3 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +18.0 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of CBPE use?
Our models discount Citra Buana Prasida at 12.0 %: a base by market capitalisation (nano), country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Citra Buana Prasida that is +1.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.0 %) and the same formula as our fair value.
How much growth has Citra Buana Prasida (CBPE) delivered so far?
Over the past 5 years revenue at Citra Buana Prasida grew +18.0 % a year. The price currently implies free-cash-flow growth of +1.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Citra Buana Prasida (CBPE) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Citra Buana Prasida (+1.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Citra Buana Prasida (CBPE)?
The free-cash-flow yield on the price is 8.22 %: that much free cash flow Citra Buana Prasida produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Citra Buana Prasida (CBPE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Citra Buana Prasida it is 835.05 IDR per share (as of Nov 3, 2026), against a price of 490.00 IDR. It is the blended result of 16 valuation models in 6 families (DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Citra Buana Prasida stock overvalued or undervalued in 2026?
As of Nov 3, 2026, CBPE trades below its calculated fair value: price 490.00 IDR, fair value 835.05 IDR, a gap of about +70% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CBPE?
No. The price is what the market pays today (490.00 IDR); the fair value is what the company's own numbers justify (835.05 IDR). For Citra Buana Prasida the two are 345.05 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Citra Buana Prasida worth?
The market values Citra Buana Prasida at about 665B IDR (market capitalisation, as of Nov 3, 2026). Per share that is 490.00 IDR; our models calculate a fair value of 835.05 IDR per share.
What do the bullish and bearish scenarios say about CBPE?
Our models span a range for Citra Buana Prasida: cautious scenario 542.07 IDR, base 835.05 IDR, optimistic 1,399 IDR per share (as of Nov 3, 2026, price 490.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Citra Buana Prasida (CBPE)?
Balance-sheet figures for Citra Buana Prasida (as of Nov 3, 2026): return on equity 19.7%, debt of 0.02 per unit of equity. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is CBPE from its 52-week high?
Citra Buana Prasida trades at 490.00 IDR, about 22% below its 52-week high of 630.00 IDR and 89% above the low of 259.06 IDR (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 835.05 IDR is for.
Which stocks are comparable to Citra Buana Prasida?
From the same area (Real Estate) we also value Sun Hung Kai Properties Limited, China Resources Land Limited, CK Asset Holdings, DLF Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Citra Buana Prasida stock attractive at the current price?
The data as of Nov 3, 2026: price 490.00 IDR, calculated fair value 835.05 IDR (+70%), Quality Score 66/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CBPE calculated?
We run Citra Buana Prasida through 16 models from 6 families: DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 835.05 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Citra Buana Prasida currently trades 41% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Citra Buana Prasida (CBPE)?
The closing price on Nov 9, 2026 was 490.00 IDR. Our model-based fair value is 835.05 IDR, about +70% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Citra Buana Prasida right now?
The price is below even our cautious bear case (542.07 IDR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (542.07 IDR to 1,399 IDR) leaves room in how you read the outcome.
Key figures of Citra Buana Prasida
How large is the market capitalisation of Citra Buana Prasida (CBPE)?
The market capitalisation of Citra Buana Prasida is 665B IDR (≈ $36.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Citra Buana Prasida (CBPE)?
The price-to-sales ratio of Citra Buana Prasida is 5.89 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Citra Buana Prasida (CBPE)?
The net margin of Citra Buana Prasida is 59.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Citra Buana Prasida (CBPE)?
The return on equity (ROE) of Citra Buana Prasida is 19.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Citra Buana Prasida (CBPE)?
On an EBIT basis the return on assets of Citra Buana Prasida is 15.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Citra Buana Prasida (CBPE)?
The operating margin of Citra Buana Prasida is 45.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Citra Buana Prasida (CBPE)?
Revenue at Citra Buana Prasida is growing +14.2% versus a year earlier (3y avg +15.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Citra Buana Prasida (CBPE)?
Earnings per share at Citra Buana Prasida are growing +25.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Citra Buana Prasida (CBPE) hold?
Citra Buana Prasida holds more cash than debt, 120B IDR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Citra Buana Prasida in the live analysis
One click puts Citra Buana Prasida on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 3, 2026